| Market Size 2023 (Base Year) | USD 71.39 Billion |
| Market Size 2032 (Forecast Year) | USD 731.21 Billion |
| CAGR | 29.5% |
| Forecast Period | 2024 - 2032 |
| Historical Period | 2018 - 2023 |
According to Market Research Store, the global mHealth Devices and Services market size was valued at around USD 71.39 billion in 2023 and is estimated to reach USD 731.21 billion by 2032, to register a CAGR of approximately 29.5% in terms of revenue during the forecast period 2024-2032.
The mHealth Devices and Services report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.

To Get more Insights, Request a Free Sample
mHealth Devices and Services refer to the use of mobile and wireless technologies to support medical and public health practices. These include wearable devices like fitness trackers, smartwatches, mobile ECG monitors, glucometers, and portable blood pressure monitors, as well as smartphone apps and cloud-based platforms that enable health tracking, diagnostics, treatment adherence, remote consultations, and real-time health data sharing. mHealth tools empower users to monitor their own health and support healthcare providers in delivering personalized, data-driven care outside traditional clinical settings.
The growth of the mHealth devices and services market is driven by increasing smartphone penetration, rising awareness of preventive healthcare, and the global shift toward digital health solutions. These technologies offer improved access to healthcare in remote and underserved regions, enable chronic disease management, and support healthy lifestyle habits. Integration with telehealth platforms, electronic health records (EHRs), and AI-powered analytics further enhances the effectiveness of mHealth by enabling early diagnosis, continuous monitoring, and timely interventions. As healthcare systems strive for more cost-effective, patient-centered models of care, mHealth is playing a critical role in transforming how health services are accessed, delivered, and managed globally.
Key Growth Drivers:
Restraints:
Opportunities:
Challenges:
This report thoroughly analyzes the mHealth Devices and Services Market, exploring its historical trends, current state, and future projections. The market estimates presented result from a robust research methodology, incorporating primary research, secondary sources, and expert opinions. These estimates are influenced by the prevailing market dynamics as well as key economic, social, and political factors. Furthermore, the report considers the impact of regulations, government expenditures, and advancements in research and development on the market. Both positive and negative shifts are evaluated to ensure a comprehensive and accurate market outlook.
| Report Attributes | Report Details |
|---|---|
| Report Name | mHealth Devices and Services Market |
| Market Size in 2023 | USD 71.39 Billion |
| Market Forecast in 2032 | USD 731.21 Billion |
| Growth Rate | CAGR of 29.5% |
| Number of Pages | 150 |
| Key Companies Covered | AT&T, Inc., Bayer HealthCare AG, BioTelemetry, Inc., Boston Scientific Corporation, DexCom, Inc., Dräger AG, F. Hoffmann La-Roche Ltd., Johnson & Johnson, LifeWatch AG, Masimo Corporation, Medtronic, Inc. and Omron Healthcare. |
| Segments Covered | By Product, By Service, By, And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2023 |
| Forecast Year | 2024 to 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global mHealth Devices and Services market is divided by product, service, and region.
Based on product, the global mHealth Devices and Services market is divided into glucose monitors, blood pressure monitors, cardiac monitors, pulse oximeters, sleep apnea monitors, multi-parameter monitors, and others. Glucose Monitors are the dominant product segment in the mHealth Devices and Services Market, driven by the global rise in diabetes prevalence and the growing demand for continuous blood sugar monitoring. These devices include both traditional glucometers and continuous glucose monitors (CGMs), many of which are Bluetooth-enabled for real-time data transmission to mobile health apps. Glucose monitors allow patients to track their glucose levels conveniently, enabling better self-management and improved treatment adherence. Their compatibility with smartphones and integration with digital health platforms makes them highly valuable in both clinical and remote settings. Governments and healthcare providers are increasingly supporting the use of glucose monitors as part of chronic disease management programs, further boosting this segment's dominance.
On the basis of service, the global mHealth Devices and Services market is bifurcated into remote monitoring, fitness and wellness, diagnosis and consultation, and others. Remote Monitoring is the dominant service segment in the mHealth Devices and Services Market, driven by the increasing demand for continuous, real-time patient data and the global shift toward value-based care. This service involves the use of connected health devices to track vital signs such as blood pressure, glucose levels, heart rate, and oxygen saturation from the comfort of a patient’s home. Remote monitoring has become an essential component of chronic disease management, elderly care, and post-discharge recovery, helping healthcare providers detect complications early, reduce hospital readmissions, and personalize treatment plans. Its adoption was significantly accelerated during the COVID-19 pandemic and remains high due to cost efficiency, improved patient outcomes, and the widespread availability of mobile health platforms. Insurers and governments increasingly support remote monitoring services through reimbursements and public health initiatives, further strengthening its dominance.
North America dominates the mHealth devices and services market, supported by widespread smartphone penetration, high healthcare expenditure, and strong adoption of digital health technologies. The United States leads due to a well-established ecosystem of telehealth, remote monitoring, and health-related mobile apps integrated with wearable devices such as smartwatches, fitness bands, glucometers, ECG monitors, and blood pressure trackers. The region benefits from a growing elderly population, rising chronic disease prevalence, and patient-centric healthcare reforms encouraging home-based monitoring. Major tech companies and healthcare providers collaborate to offer end-to-end mobile health solutions, including data analytics and AI-driven insights. The strong regulatory support from agencies like the FDA and favorable reimbursement policies further reinforce growth. Canada is also contributing significantly, especially in rural telehealth, chronic disease management, and digital patient engagement platforms.
Europe holds a significant share in the mHealth devices and services market, driven by progressive healthcare digitization, a strong regulatory framework, and increasing demand for remote healthcare solutions. Countries such as Germany, the UK, France, and the Netherlands lead the region with national health systems adopting mHealth tools for preventive care, remote diagnosis, and chronic condition management. The European Commission promotes cross-border health data exchange and integration of digital health platforms, enhancing patient access and care coordination. Devices such as remote heart monitors, mobile spirometers, and connected diagnostic kits are widely used in public health initiatives and personal wellness programs. GDPR compliance and stringent data security measures also play a pivotal role in shaping the market landscape across the continent.
Asia-Pacific is the fastest-growing region in the mHealth devices and services market, driven by expanding mobile connectivity, a large patient base, and increasing healthcare accessibility challenges. China, India, Japan, and South Korea are key contributors. In China, state-driven digital health infrastructure and high smartphone adoption support extensive use of mobile platforms for teleconsultation, prescription services, and health tracking. In India, mHealth is growing rapidly due to the wide use of mobile devices for managing diabetes, hypertension, and maternal health, particularly in rural and semi-urban areas. Japan and South Korea, with aging populations and advanced technology integration, are deploying wearable monitors and health management apps in elder care. Despite challenges such as regulatory variability and uneven infrastructure, investment in health tech startups and public-private partnerships continues to accelerate regional market expansion.
Latin America is an emerging market for mHealth devices and services, with Brazil, Mexico, Argentina, and Chile showing growing adoption. Rising healthcare costs, limited access to medical facilities in rural areas, and the increasing burden of chronic diseases have led to the development of mobile-based health platforms. Brazil is leading with mobile-enabled diagnostic services, fitness tracking apps, and virtual consultations. Mexico is expanding its use of wearable devices in wellness programs and home-based monitoring. Regional governments are increasingly supporting mHealth initiatives to improve healthcare access and efficiency. However, barriers such as low digital literacy, infrastructure limitations, and lack of standardized regulations still affect the pace of growth.
Middle East & Africa are developing regions in the mHealth devices and services market, with growing demand for mobile health solutions to address provider shortages and healthcare access gaps. In the Middle East, the UAE and Saudi Arabia are investing in telemedicine platforms, mobile diagnostics, and remote monitoring to support national healthcare transformation agendas. These services are increasingly integrated into public and private healthcare systems. In Africa, countries like South Africa, Kenya, and Nigeria are adopting mobile health solutions to reach underserved populations, particularly in maternal health, infectious disease tracking, and chronic care. Although challenges such as infrastructure deficits, affordability, and inconsistent regulation remain, rising mobile penetration and global health collaborations are steadily improving regional adoption and implementation of mHealth technologies.
The report provides an in-depth analysis of companies operating in the mHealth Devices and Services market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.
Some of the major players in the global mHealth Devices and Services market include:
By Product
By Service
By Region
mHealth Devices and Services
mHealth Devices and Services
×